For more information, Please click Ovarian Cancer Market.
DelveInsight Blog
Trending:
VBL Therapeutics’ VB-111 (ofranergene obad...
May 03, 2022
FDA Grants Fast Track Designation to VB-111 for Platinium-resistant Ovarian Cancer The FDA has given VBL Therapeutics...
Precigen’s PRGN-3006; Yescarta Appro...
Apr 05, 2022
FDA Approves Yescarta as a First CAR T-cell Therapy for Initial Treatment of R/R Large B-cell Lymphoma Until now, exi...
Ypsomed-CamDiab’s Collaboration; Vel...
Mar 31, 2022
Ypsomed Collaborated with CamDiab for Smartphone-based Automated Insulin Delivery On March 22, 2022, Ypsomed, a leadi...
Sign Up and Stay Informed
Penetrative insights and rich analysis of Pharma, Biotech and MedTech space.
Editor's Pick
Commercial Roadmap for the Launch: What can Biopharmaceuticals do to Increase...
The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of...
Emerging Market for Organ on a Chip
The organ on a chip is a microfluidic culture device that recapitulates the complicated...
Global Top Players in Intraocular Lens (IOL) Market
An Intraocular Lens implant is a synthetic, artificial lens placed inside the eye...
Investigating the Pipeline for Ankylosing Spondylitis Treatment Landscape
Ankylosing Spondylitis is a form of arthritis that primarily affects the spine. It caus...
LAG 3: A Promising Next Generation Cancer Immunotherapy
Immunotherapy also called biologic therapy, is a type of cancer treatment that boosts t...
RECENT ARTICLES
.png)
